Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop.
Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote AU, Greiner W, Hanquet G, Harder T, Hutubessy R, Jit M, Knol M, Kuhlmann A, von Kries R, Levy-Bruhl D, Perleth M, Postma MJ, Salo H, Siebert U, Wasem J, Weidemann F, Wichmann O. Ultsch B, et al. Among authors: bruggenjurgen b. Value Health. 2014 Nov;17(7):A552. doi: 10.1016/j.jval.2014.08.1803. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201800 Free article. No abstract available.
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O. Ultsch B, et al. Among authors: bruggenjurgen b. Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2. Pharmacoeconomics. 2016. PMID: 26477039 Free PMC article.
[Methods of health economic evaluation for health services research].
Icks A, Chernyak N, Bestehorn K, Brüggenjürgen B, Bruns J, Damm O, Dintsios CM, Dreinhöfer K, Gandjour A, Gerber A, Greiner W, Hermanek P, Hessel F, Heymann R, Huppertz E, Jacke C, Kächele H, Kilian R, Klingenberger D, Kolominsky-Rabas P, Krämer H, Krauth C, Lüngen M, Neumann T, Porzsolt F, Prenzler A, Pueschner F, Riedel R, Rüther A, Salize HJ, Scharnetzky E, Schwerd W, Selbmann HK, Siebert H, Stengel D, Stock S, Völler H, Wasem J, Schrappe M. Icks A, et al. Among authors: bruggenjurgen b. Gesundheitswesen. 2010 Dec;72(12):917-33. doi: 10.1055/s-0030-1262859. Epub 2010 Sep 23. Gesundheitswesen. 2010. PMID: 20865653 German.
Economic and human costs of restless legs syndrome.
Reinhold T, Müller-Riemenschneider F, Willich SN, Brüggenjürgen B. Reinhold T, et al. Among authors: bruggenjurgen b. Pharmacoeconomics. 2009;27(4):267-79. doi: 10.2165/00019053-200927040-00001. Pharmacoeconomics. 2009. PMID: 19485424 Review.
[Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
Krauth C, John J, Aidelsburger P, Brüggenjürgen B, Hansmeier T, Hessel F, Kohlmann T, Moock J, Rothgang H, Schweikert B, Seitz R, Wasem J; AG Methoden der gesundheitsökonomischen Evaluation. Krauth C, et al. Among authors: bruggenjurgen b. Gesundheitswesen. 2008 Jun;70(6):e1-16. doi: 10.1055/s-2008-1077059. Gesundheitswesen. 2008. PMID: 18661452 German.
Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry.
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Brüggenjürgen B, et al. Value Health. 2014 Nov;17(7):A493. doi: 10.1016/j.jval.2014.08.1464. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201472 Free article. No abstract available.
Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry.
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Brüggenjürgen B, et al. Value Health. 2014 Nov;17(7):A497. doi: 10.1016/j.jval.2014.08.1484. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201497 Free article. No abstract available.
80 results